{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T21:59:11Z","timestamp":1790027951266,"version":"4.0.1"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To develop and validate a pretreatment computed tomography (CT)-derived model for predicting major pathological response (MPR) to neoadjuvant immunochemotherapy in resectable non-small-cell lung cancer (NSCLC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This multicenter retrospective study included 287 patients with stage IB-III NSCLC treated with neoadjuvant immunotherapy plus chemotherapy followed by surgery. Patients from Center A formed the training cohort (n = 224), and patients from Center B formed the external validation cohort (n = 63). Two-dimensional (2D) and three-dimensional (3D) intratumoral heterogeneity scores (ITHscores) were derived from venous-phase pretreatment CT using local radiomics, K-means clustering and connected-component topology. Candidate predictors included clinicopathological variables, ITHscores and blood-derived inflammatory indicators. Eight machine-learning algorithms were compared, and the final model was selected using cross-validation and feature ablation. Shapley additive explanations (SHAP) analysis was used to interpret feature contributions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Non-MPR tumors showed significantly higher 2D and 3D ITHscores than MPR tumors in both cohorts (all P &amp;lt; 0.001). CatBoost was selected as the optimal algorithm. SHAP analysis identified 2D ITHscore and 3D ITHscore as the two most influential predictors, with mean absolute SHAP values of 0.403 and 0.326, respectively. The final parsimonious model retained 2D ITHscore, 3D ITHscore and systemic immune-inflammation index. It achieved AUCs of 0.824 in the training cohort and 0.792 in the external validation cohort, outperforming the clinical and ITH-only models. Calibration and decision curve analyses showed acceptable agreement and potential clinical utility.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>CT-derived topological intratumoral heterogeneity, combined with systemic inflammation, may provide a non-invasive pretreatment biomarker for predicting MPR in resectable NSCLC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1898208","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T05:39:16Z","timestamp":1785130756000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["CT-derived topological intratumoral heterogeneity predicts major pathological response to neoadjuvant immunochemotherapy in resectable non-small-cell lung cancer: a two-center study"],"prefix":"10.3389","volume":"17","author":[{"given":"Yongjie","family":"Zhou","sequence":"first","affiliation":[{"name":"Department of Radiology, Jiangxi Cancer Hospital & Institute, Jiangxi Clinical Research Center for Cancer, The Second Affiliated Hospital of Nanchang Medical College","place":["Nanchang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingyu","family":"Hong","sequence":"additional","affiliation":[{"name":"Liaoning University of Traditional Chinese Medicine","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongliang","family":"Qi","sequence":"additional","affiliation":[{"name":"Department of Clinical Engineering, Southern Medical University, Nanfang Hospital","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhong","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Radiology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University","place":["Nanchang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengyang","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Radiology, Jiangxi Cancer Hospital & Institute, Jiangxi Clinical Research Center for Cancer, The Second Affiliated Hospital of Nanchang Medical College","place":["Nanchang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Radiology, Jiangxi Cancer Hospital & Institute, Jiangxi Clinical Research Center for Cancer, The Second Affiliated Hospital of Nanchang Medical College","place":["Nanchang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Radiology, Jiangxi Cancer Hospital & Institute, Jiangxi Clinical Research Center for Cancer, The Second Affiliated Hospital of Nanchang Medical College","place":["Nanchang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Zou","sequence":"additional","affiliation":[{"name":"Department of Radiology, Jiangxi Cancer Hospital & Institute, Jiangxi Clinical Research Center for Cancer, The Second Affiliated Hospital of Nanchang Medical College","place":["Nanchang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1056\/NEJMc2208133","article-title":"Neoadjuvant nivolumab plus chemotherapy in lung cancer","volume":"387","author":"Tanvetyanon","year":"2022","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1056\/NEJMc2313778","article-title":"Perioperative durvalumab for resectable non-small-cell lung cancer","volume":"390","author":"Horita","year":"2024","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1056\/NEJMc2407267","article-title":"Perioperative nivolumab in resectable lung cancer","volume":"391","author":"Sorscher","year":"2024","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02660-6","article-title":"Association between pathologic response and survival after neoadjuvant therapy in lung cancer","volume":"30","author":"Deutsch","year":"2024","journal-title":"Nat Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2024.03.010","article-title":"Evaluation of major pathologic response and pathologic complete response as surrogate end points for survival in randomized controlled trials of neoadjuvant immune checkpoint blockade in resectable in NSCLC","volume":"19","author":"Hines","year":"2024","journal-title":"J Thorac Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2022.103582","article-title":"PD-L1 expression and tumor mutation burden as pathological response biomarkers of neoadjuvant immunotherapy for early-stage non-small cell lung cancer: a systematic review and meta-analysis","volume":"170","author":"Deng","year":"2022","journal-title":"Crit Rev Oncol Hematol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.21037\/tlcr-24-598","article-title":"Predictive value of longitudinal systemic inflammatory markers for pathologic response to neoadjuvant PD-1 blockade in resectable non-small cell lung cancer","volume":"13","author":"Tao","year":"2024","journal-title":"Trans Lung Cancer Res"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-021-00560-7","article-title":"Predicting cancer outcomes with radiomics and artificial intelligence in radiology","volume":"19","author":"Bera","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2025.112171","article-title":"Non-invasive CT based multiregional radiomics for predicting pathologic complete response to preoperative neoadjuvant chemoimmunotherapy in non-small cell lung cancer","volume":"189","author":"Fan","year":"2025","journal-title":"Eur J Radiol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.crad.2025.106906","article-title":"Delta-radiomics features combined with haematological index predict pathological complete response after neoadjuvant immunochemotherapy in resectable non-small cell lung cancer","volume":"86","author":"Xiong","year":"2025","journal-title":"Clin Radiol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-bioeng-031825-040442","article-title":"Radiomics++: Review of habitat imaging analysis for decoding tumor heterogeneity","volume":"28","author":"Wu","year":"2026","journal-title":"Annu Rev BioMed Eng"},{"key":"B12","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s40644-024-00758-9","article-title":"MRI-based habitat imaging in cancer treatment: current technology, applications, and challenges","volume":"24","author":"Li","year":"2024","journal-title":"Cancer Imaging"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-024-01111-8","article-title":"Cancer immune evasion, immunoediting and intratumour heterogeneity","volume":"25","author":"Roerden","year":"2025","journal-title":"Nat Rev Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-025-18815-3","article-title":"Development and validation of time-to-event machine learning models for predicting disease-free survival in patients with locally advanced colorectal cancer: a multicenter cohort study","volume":"33","author":"Zhou","year":"2026","journal-title":"Ann Surg Oncol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2026.111756","article-title":"Preoperative CT-based topologically distinct intratumoral heterogeneity scores for predicting intratumoral tertiary lymphoid structures and outcomes in hepatocellular carcinoma: a multicenter study","volume":"52","author":"Zhao","year":"2026","journal-title":"Ejso"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pdig.0001246","article-title":"Topologically distinct 2D and 3D intratumoral heterogeneity scores for preoperatively predicting invasiveness in stage I lung adenocarcinoma: a multicenter study","volume":"5","author":"Zuo","year":"2026","journal-title":"PloS Digit Health"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1115291","article-title":"Development and validation of a radiomics-based nomogram for predicting a major pathological response to neoadjuvant immunochemotherapy for patients with potentially resectable non-small cell lung cancer","volume":"14","author":"Liu","year":"2023","journal-title":"Front Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1414954","article-title":"CT-based quantification of intratumoral heterogeneity for predicting pathologic complete response to neoadjuvant immunochemotherapy in non-small cell lung cancer","volume":"15","author":"Ye","year":"2024","journal-title":"Front Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.mri.2012.05.001","article-title":"3D Slicer as an image computing platform for the Quantitative Imaging Network","volume":"30","author":"Fedorov","year":"2012","journal-title":"Magn Reson Imaging"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2020191145","article-title":"The Image Biomarker Standardization Initiative: Standardized quantitative radiomics for high-throughput image-based phenotyping","volume":"295","author":"Zwanenburg","year":"2020","journal-title":"Radiology"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-17-0339","article-title":"Computational radiomics system to decode the radiographic phenotype","volume":"77","author":"van Griethuysen","year":"2017","journal-title":"Cancer Res"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/advs.75780","article-title":"Noninvasive characterization of tumor heterogeneity in HNSCC: from clinical utility to biological correlates","volume":"19","author":"Chen","year":"2026","journal-title":"Adv Sci"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmpb.2025.108874","article-title":"Interpretable machine learning models based on body composition and inflammatory nutritional index (BCINI) to predict early postoperative recurrence of colorectal cancer: multi-center study","volume":"269","author":"Zhou","year":"2025","journal-title":"Comput Methods Programs BioMed"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.21037\/tlcr-24-17","article-title":"Efficacy of neoadjuvant chemo-immunotherapy in non-small cell lung cancer: a real-world, multicenter, retrospective study","volume":"13","author":"Wang","year":"2024","journal-title":"Trans Lung Cancer Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtocrr.2022.100420","article-title":"Major pathologic response and prognostic score predict survival in patients with lung cancer receiving neoadjuvant chemotherapy","volume":"3","author":"Pataer","year":"2022","journal-title":"Jto Clin Res Rep"},{"key":"B26","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/s00330-022-09055-0","article-title":"ITHscore: Comprehensive quantification of intra-tumor heterogeneity in NSCLC by multi-scale radiomic features","volume":"33","author":"Li","year":"2023","journal-title":"Eur Radio"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1111\/cas.15964","article-title":"Peripheral blood inflammatory biomarkers dynamics reflect treatment response and predict prognosis in non-small cell lung cancer patients with neoadjuvant immunotherapy","volume":"114","author":"Huai","year":"2023","journal-title":"Cancer Sci"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1422717","article-title":"Dynamics of peripheral blood inflammatory index predict tumor pathological response and survival among patients with locally advanced non-small cell lung cancer who underwent neoadjuvant immunochemotherapy: a multi-cohort retrospective study","volume":"15","author":"Zhai","year":"2024","journal-title":"Front Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1244256","article-title":"Combined inflammatory parameters and tertiary lymphoid structure predict prognosis in patients with resectable non-small cell lung cancer treated with neoadjuvant chemoimmunotherapy","volume":"14","author":"Xu","year":"2023","journal-title":"Front Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1186\/s12876-026-04772-y","article-title":"Interpretable stacking model integrating intra-\/peritumoral CT-radiomics and serum biomarkers for predicting microvascular invasion in HCC: a dual-center retrospective study","volume":"26","author":"Wang","year":"2026","journal-title":"BMC Gastroenterol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.acra.2024.12.030","article-title":"CT multidimensional radiomics combined with inflammatory immune score for preoperative prediction of pathological grade in esophageal squamous cell carcinoma","volume":"32","author":"Zheng","year":"2025","journal-title":"Acad Radiol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1898208\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T05:39:17Z","timestamp":1785130757000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1898208\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,27]]},"references-count":31,"alternative-id":["10.3389\/fimmu.2026.1898208"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1898208","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,27]]},"article-number":"1898208"}}